Home › Leiomyosarcoma › New York
Leiomyosarcoma clinical trials in New York
4 studies for Leiomyosarcoma are looking for participants at sites in New York.
Cities in New York
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Roswell Park Cancer Institute, Buffalo
- Northwell Health/Center for Advanced Medicine, Lake Success
- North Shore University Hospital, Manhasset
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT04031677A Study of Ivonescimab in People With Leiomyosarcoma
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07516925STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Northwell Health Cancer Institute, Lake Success
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06975293Metastatic Leiomyosarcoma Biomarker Protocol
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05653388From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.